Incidence of Atrial Fibrillation in Elite Athletes

dc.contributor.authorBoraita, Araceli
dc.contributor.authorSantos Lozano, Alejandro
dc.contributor.authorHeras Gómez, María Eugenia
dc.contributor.authorGonzález Amigo, Florencia
dc.contributor.authorLópez Ortiz, Susana
dc.contributor.authorVillacastín, Julián P.
dc.contributor.authorLucía Mulas, Alejandro
dc.date.accessioned2019-01-22T19:03:19Z
dc.date.available2019-01-22T19:03:19Z
dc.date.issued2018
dc.description.abstractImportance Vigorous exercise (particularly endurance sports) might increase the risk of atrial fibrillation (AF), but there is variability in the reported frequency of this condition among elite athletes. The underlying pathophysiologic source remains unclear. Objective To determine AF incidence in a large cohort of elite athletes and its association with potential risk factors. Design, Setting, and Participants Retrospective observational cohort of all Spanish athletes (N = 6813) referred to a single center was used to determine AF incidence from January 1, 1997, to December 31, 2017, and cross-sectional analysis was conducted to compare athletes with and without reported AF. The cohort covered most sports disciplines, and the studied athletes were on national teams and competed in major international events. Cardiologists responsible for echocardiographic assessment were not blinded to the condition (AF or no AF) of the athletes. Exposures All participants underwent at least 1 cardiologic evaluation, including assessment at time of AF diagnosis in those with this condition. Main Outcomes and Measures Diagnosis of AF based on resting and/or exercise electrocardiogram, and/or 24-hour Holter monitoring and echocardiography-assessed atrial dimensions. Results A total of 6813 Spanish elite athletes (2385 [35.0%] women) were referred for cardiac evaluation during the study period. Mean (SD) age was 22 (7) years, and mean (SD) time of competition was 8 (5) years. Only 21 athletes (1 woman), participating in different types of sports, had AF (ie, paroxysmal [n = 18], persistent [n = 1], or long-standing persistent [n = 2]) during the 20-year study. In multivariate analysis, increasing values of age (odds ratio [OR], 1.07; 95% CI, 1.00-1.14), years of competition (OR, 1.14; 95% CI, 1.07-1.22), and left atrial anteroposterior diameter (OR, 1.21; 95% CI, 1.10-1.32) were associated with higher AF risk. Conclusions and Relevance The incidence of AF is low among young Spanish elite athletes, even when considering only endurance athletes. Yet, potential contributors (particularly atrial remodeling) need to be monitored.spa
dc.description.filiationUEMspa
dc.description.impact11.866 JCR (2018) Q1, 7/136 Cardiac & Cardiovascular Systemspa
dc.description.impact6.06 SJR (2018) Q1, 4/365 Cardiology and Cardiovascular Medicinespa
dc.description.impactNo data IDR 2018spa
dc.description.sponsorshipSin financiaciónspa
dc.identifier.citationBoraita, A., Santos-Lozano, A., Heras, M. E., González-Amigo, F., López-Ortiz, S., Villacastín, J. P., & Lucia, A. (2018). Incidence of Atrial Fibrillation in Elite Athletes. JAMA cardiology, 3(12), 1200-1205. https://doi.org/10.1001/jamacardio.2018.3482spa
dc.identifier.doi10.1001/jamacardio.2018.3482
dc.identifier.issn2380-6583
dc.identifier.issn2380-6591
dc.identifier.urihttp://hdl.handle.net/11268/7736
dc.language.isoengspa
dc.peerreviewedSispa
dc.rights.accessRightsopen accessspa
dc.subject.uemDeportistasspa
dc.subject.uemSistema cardiovascularspa
dc.subject.uemEfectos fisiológicosspa
dc.subject.unescoSistema cardiovascularspa
dc.subject.unescoAtletaspa
dc.subject.unescoEfectos fisiológicosspa
dc.titleIncidence of Atrial Fibrillation in Elite Athletesspa
dc.typejournal articlespa
dspace.entity.typePublication
relation.isAuthorOfPublicationd3691359-d7bd-4a12-b84e-338e28c81f9f
relation.isAuthorOfPublication.latestForDiscoveryd3691359-d7bd-4a12-b84e-338e28c81f9f

Files

Collections